Home / Valsartan and Diuretics / Italy
IT ATC C09DA03 · updated 2 Nov 2026
Valsartan and Diuretics shortage in Italy
Is there a Valsartan and Diuretics shortage in Italy?
Yes. As of 2 Nov 2026, 14 Valsartan and Diuretics products are reported short in Italy, the first since 14 Jul 2025. The company estimate for the return is 31 Jan 2027 (latest 30 Jun 2027). Main reason: manufacturing problem.
Also short in Canada, Germany, Spain, Austria, Belgium, Czechia. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | VALSARTAN E IDROCLOROTIAZIDE HCS | HCS BV | 14 Jul 2025 | not given | Commercial decision or withdrawal Motivi commerciali |
| IT | VALSARTAN E IDROCLOROTIAZIDE MYLAN | MYLAN S.P.A. | 30 Jul 2025 | not given | Manufacturing problem Problemi produttivi |
| IT | VALSARTAN E IDROCLOROTIAZIDE MYLAN | MYLAN S.P.A. | 4 Aug 2025 | not given | Manufacturing problem Problemi produttivi |
| IT | VALSARTAN E IDROCLOROTIAZIDE MYLAN | MYLAN S.P.A. | 6 Feb 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | VALSARTAN E IDROCLOROTIAZIDE MYLAN | MYLAN S.P.A. | 22 Mar 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | VALSARTAN E IDROCLOROTIAZIDE HCS | HCS BV | 26 Mar 2026 | not given | Commercial decision or withdrawal Motivi commerciali |
| IT | VALSARTAN E IDROCLOROTIAZIDE HCS | HCS BV | 24 Apr 2026 | not given | Commercial decision or withdrawal Motivi commerciali |
| IT | VALSARTAN E IDROCLOROTIAZIDE AUROBINDO | AUROBINDO PHARMA (ITALIA) S.R.L. | 27 Aug 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | VALSARTAN E IDROCLOROTIAZIDE SANDOZ | SANDOZ S.P.A. | 1 Oct 2026 | not given | Manufacturing problem Problemi produttivi: forniture discontinue |
| IT | VALSARTAN E IDROCLOROTIAZIDE TEVA ITALIA | TEVA ITALIA S.R.L. | 26 Oct 2026 | 31 Jan 2027 | Increased demand Elevata richiesta |
| IT | VALSARTAN E IDROCLOROTIAZIDE TEVA anticipated | TEVA ITALIA S.R.L. | 30 Nov 2026 | 31 Jan 2027 | Increased demand Elevata richiesta/problemi produttivi (carenza relativa solo al canale retail) |
| IT | VALSARTAN E IDROCLOROTIAZIDE PENSA anticipated | TOWA PHARMACEUTICAL S.P.A. | 1 Dec 2026 | 30 Jun 2027 | Increased demand Elevata richiesta/problemi produttivi |
| IT | VALSARTAN E IDROCLOROTIAZIDE TEVA ITALIA anticipated | TEVA ITALIA S.R.L. | 7 Dec 2026 | 31 Jan 2027 | Increased demand Elevata richiesta/problemi produttivi |
| IT | VALSARTAN E IDROCLOROTIAZIDE AUROBINDO anticipated | AUROBINDO PHARMA (ITALIA) S.R.L. | 22 Dec 2026 | not given | Manufacturing problem Problemi produttivi |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.